Restricted Mean Survival Time Analysis to Estimate SGLT2i–Associated Heterogeneous Treatment Effects on Primary and Secondary Prevention of Cardiorenal Outcomes in Patients With Type 2 Diabetes in Taiwan

IMPORTANCE: Increasing numbers of post hoc analyses have applied restricted mean survival time (RMST) analysis on the aggregated-level data from clinical trials to report treatment effects, but studies that use individual-level claims data are needed to determine the feasibility of RMST analysis for...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Zi-Yang, Yang, Chun-Ting, Kuo, Shihchen, Wu, Chih-Hsing, Lin, Wei-Hung, Ou, Huang-Tz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856417/
https://www.ncbi.nlm.nih.gov/pubmed/36520437
http://dx.doi.org/10.1001/jamanetworkopen.2022.46928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856417/
https://www.ncbi.nlm.nih.gov/pubmed/36520437
http://dx.doi.org/10.1001/jamanetworkopen.2022.46928

Ejemplares similares